- Home
- HSDT vs OUSTW Comparison
HSDT vs OUSTW Comparison
Compare HSDT & OUSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSDT
- OUSTW
- Stock Information
- Founded
- HSDT 2014
- OUSTW N/A
- Country
- HSDT United States
- OUSTW United States
- Employees
- HSDT N/A
- OUSTW N/A
- Industry
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OUSTW Industrial Machinery/Components
- Sector
- HSDT Health Care
- OUSTW Industrials
- Exchange
- HSDT Nasdaq
- OUSTW Nasdaq
- Market Cap
- HSDT 2.9M
- OUSTW 3.1M
- IPO Year
- HSDT N/A
- OUSTW N/A
- Fundamental
- Price
- HSDT $0.54
- OUSTW $0.04
- Analyst Decision
- HSDT Buy
- OUSTW
- Analyst Count
- HSDT 2
- OUSTW 0
- Target Price
- HSDT $24.00
- OUSTW N/A
- AVG Volume (30 Days)
- HSDT 241.1K
- OUSTW N/A
- Earning Date
- HSDT 03-27-2025
- OUSTW N/A
- Dividend Yield
- HSDT N/A
- OUSTW N/A
- EPS Growth
- HSDT N/A
- OUSTW N/A
- EPS
- HSDT N/A
- OUSTW N/A
- Revenue
- HSDT $502,000.00
- OUSTW N/A
- Revenue This Year
- HSDT N/A
- OUSTW N/A
- Revenue Next Year
- HSDT $8.97
- OUSTW N/A
- P/E Ratio
- HSDT N/A
- OUSTW N/A
- Revenue Growth
- HSDT N/A
- OUSTW N/A
- 52 Week Low
- HSDT $0.37
- OUSTW N/A
- 52 Week High
- HSDT $7.19
- OUSTW N/A
- Technical
- Relative Strength Index (RSI)
- HSDT 43.07
- OUSTW N/A
- Support Level
- HSDT $0.50
- OUSTW N/A
- Resistance Level
- HSDT $0.60
- OUSTW N/A
- Average True Range (ATR)
- HSDT 0.06
- OUSTW 0.00
- MACD
- HSDT -0.01
- OUSTW 0.00
- Stochastic Oscillator
- HSDT 15.87
- OUSTW 0.00
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.